Jiawen Bu

588 total citations · 1 hit paper
22 papers, 390 citations indexed

About

Jiawen Bu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiawen Bu has authored 22 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiawen Bu's work include Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (3 papers). Jiawen Bu is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), RNA modifications and cancer (5 papers) and MicroRNA in disease regulation (3 papers). Jiawen Bu collaborates with scholars based in China and United States. Jiawen Bu's co-authors include Jinqi Xue, Yueting Hu, Xi Gu, Peng Qiu, Zhenyong Zhang, Yang Liu, Jingying Li, Xudong Zhu, Xinbo Qiao and Lisha Sun and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Molecular Cancer.

In The Last Decade

Jiawen Bu

20 papers receiving 387 citations

Hit Papers

Advances in immunotherapy... 2023 2026 2024 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Advances in immunotherapy for triple-negative breast cancer
    2023 178 citations Yueting Hu, Jinqi Xue et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiawen Bu China 9 206 140 114 85 79 22 390
Qingwen Jiang United States 2 241 1.2× 163 1.2× 139 1.2× 68 0.8× 64 0.8× 3 452
Xi Gu China 11 186 0.9× 146 1.0× 158 1.4× 77 0.9× 60 0.8× 21 407
Zike Yang China 6 219 1.1× 130 0.9× 114 1.0× 89 1.0× 46 0.6× 12 419
Qiaoru Guo China 8 241 1.2× 131 0.9× 145 1.3× 54 0.6× 58 0.7× 15 437
Hui-Yen Chuang Taiwan 11 246 1.2× 124 0.9× 159 1.4× 109 1.3× 48 0.6× 18 466
Raefa Abou Khouzam France 12 201 1.0× 179 1.3× 224 2.0× 148 1.7× 87 1.1× 21 501
Renle Du China 13 231 1.1× 140 1.0× 109 1.0× 107 1.3× 53 0.7× 24 429
Xiaoyi Qiu China 7 187 0.9× 109 0.8× 109 1.0× 66 0.8× 59 0.7× 9 329
Linara Gabitova United States 8 172 0.8× 131 0.9× 165 1.4× 61 0.7× 46 0.6× 18 387
Sumit Das India 5 283 1.4× 175 1.3× 123 1.1× 58 0.7× 59 0.7× 6 468

Countries citing papers authored by Jiawen Bu

Since Specialization
Citations

This map shows the geographic impact of Jiawen Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawen Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawen Bu more than expected).

Fields of papers citing papers by Jiawen Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiawen Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawen Bu. The network helps show where Jiawen Bu may publish in the future.

Co-authorship network of co-authors of Jiawen Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiawen Bu. A scholar is included among the top collaborators of Jiawen Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiawen Bu. Jiawen Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Yang, Peng Qiu, Yang Bai, et al.. (2024). RGS10 deficiency facilitates distant metastasis by inducing epithelial–mesenchymal transition in breast cancer. eLife. 13. 2 indexed citations
4.
Su, Lin, Jiawen Bu, Jiahui Yu, et al.. (2024). Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application. Clinical and Translational Medicine. 14(11). e70066–e70066. 6 indexed citations
5.
Liu, Ruibin, Yue Wang, Jiawen Bu, et al.. (2024). Construction and Validation of Novel Ferroptosis-related Risk Score Signature and Prognostic Prediction Nomogram for Patients with Colorectal Cancer. International Journal of Medical Sciences. 21(6). 1103–1116. 1 indexed citations
6.
Bu, Jiawen, Yixiao Zhang, Sijin Wu, et al.. (2023). KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nature Communications. 14(1). 2602–2602. 36 indexed citations
7.
Zhu, Xudong, Jiawen Bu, Tong Zhu, & Yi Jiang. (2023). Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer. Journal of Translational Medicine. 21(1). 184–184. 7 indexed citations
8.
Jiang, Yi, Tong Zhu, Jiawen Bu, et al.. (2023). Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review. Journal of Cancer. 14(10). 1888–1903. 4 indexed citations
9.
Qiao, Xinbo, Yixiao Zhang, Zhan Zhang, et al.. (2023). KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes. Asian Journal of Pharmaceutical Sciences. 18(3). 100814–100814. 7 indexed citations
10.
Wang, Caizheng, Xiaoying Zhang, Jiahui Yu, et al.. (2023). Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review. Frontiers in Bioengineering and Biotechnology. 11. 1215518–1215518. 6 indexed citations
11.
Liu, Yang, et al.. (2022). Targeting ferroptosis, the achilles’ heel of breast cancer: A review. Frontiers in Pharmacology. 13. 1036140–1036140. 24 indexed citations
12.
Bu, Jiawen, Yixiao Zhang, Lisha Sun, et al.. (2022). Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer. eLife. 12. 8 indexed citations
13.
Shen, Yanyan, Jinqi Xue, Yi Jiang, et al.. (2022). Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. World Journal of Surgical Oncology. 20(1). 398–398. 1 indexed citations
14.
Xue, Jinqi, Xudong Zhu, Xinbo Qiao, et al.. (2022). CEMIP as a potential biomarker and therapeutic target for breast cancer patients. International Journal of Medical Sciences. 19(3). 434–445. 13 indexed citations
15.
Sun, Lisha, Yixiao Zhang, Guanglei Chen, et al.. (2022). Targeting SOST using a small-molecule compound retards breast cancer bone metastasis. Molecular Cancer. 21(1). 228–228. 23 indexed citations
16.
Jin, Yi, et al.. (2022). Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer. World Journal of Surgical Oncology. 20(1). 172–172. 12 indexed citations
17.
Liu, Caigang, Yixiao Zhang, Qi Zhang, et al.. (2022). A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells. Drug Resistance Updates. 66. 100903–100903. 27 indexed citations
18.
Liu, Yang, et al.. (2022). The Key Role of RNA Modification in Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 885133–885133. 8 indexed citations
19.
Jiang, Yi, Ting Liu, Jinqi Xue, et al.. (2022). The altering in sensory sensitivity: a current issue of female breast surgery. International Journal of Medical Sciences. 19(5). 901–908. 2 indexed citations
20.
Zhu, Xudong, Yang Bai, Xi Gu, et al.. (2020). HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients. International Journal of Medical Sciences. 17(17). 2773–2789. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingwen Jiang Breakdown of academic impact, for papers by Xi Gu Breakdown of academic impact, for papers by Zike Yang Breakdown of academic impact, for papers by Qiaoru Guo Breakdown of academic impact, for papers by Hui-Yen Chuang Breakdown of academic impact, for papers by Raefa Abou Khouzam Breakdown of academic impact, for papers by Renle Du Breakdown of academic impact, for papers by Xiaoyi Qiu Breakdown of academic impact, for papers by Linara Gabitova Breakdown of academic impact, for papers by Sumit Das
Rankless by CCL
2026